FHTX (STOCKS)
Foghorn Therapeutics Inc. Common Stock
$4.690000
+0.100000 (+2.18%)
Prev close: $4.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Adrian Gottschalk
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $274.72M
- Employees
- 112
- P/E (TTM)
- -3.85
- P/B (TTM)
- -2.45
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $30.91M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $117.30M |
| Nonoperating Income/Loss | $12.11M |
| Operating Expenses | $117.30M |
| Research and Development | $85.47M |
| Other Operating Expenses | $31.83M |
| Operating Income/Loss | -$86.39M |
| Income/Loss From Continuing Operations After Tax | -$74.28M |
| Income/Loss From Continuing Operations Before Tax | $30.91M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$74.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$74.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$74.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18 |
| Diluted Earnings Per Share | -$1.18 |
| Basic Average Shares | 62,980,959 |
| Diluted Average Shares | 62,980,959 |
| Assets | $198.10M |
| Current Assets | $163.24M |
| Noncurrent Assets | $34.87M |
| Liabilities | $306.60M |
| Current Liabilities | $59.74M |
| Accounts Payable | $4.27M |
| Wages | $5.92M |
| Other Current Liabilities | $49.55M |
| Noncurrent Liabilities | $246.87M |
| Equity | -$108.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$108.50M |
| Liabilities And Equity | $198.10M |
| Net Cash Flow From Operating Activities | -$86.10M |
| Net Cash Flow From Operating Activities, Continuing | -$86.10M |
| Net Cash Flow From Investing Activities | $112.04M |
| Net Cash Flow From Investing Activities, Continuing | $112.04M |
| Net Cash Flow From Financing Activities | $1.02M |
| Net Cash Flow From Financing Activities, Continuing | $1.02M |
| Net Cash Flow | $26.96M |
| Net Cash Flow, Continuing | $26.96M |
| Comprehensive Income/Loss | -$74.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$74.39M |
| Other Comprehensive Income/Loss | -$74.39M |
| Other Comprehensive Income/Loss Attributable To Parent | -$111.00K |